Document Detail

Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.
MedLine Citation:
PMID:  23500039     Owner:  NLM     Status:  Publisher    
Ophthalmic conditions in which the retinal vasculature is obstructed generally lead to vision loss. Administration of the vasodilator L-lactate might offer a treatment strategy by restoring the blood flow, but unfortunately its effect after single intravitreal injection is short-lived. This study describes a concept in which the sustained release of L-lactic acid from a biodegradable copolymer system is investigated. The 50:50 (n/n) copolymer system, composed of L-lactic acid and L,D-2-hydroxyoctanoic acid, is a viscous injectable that will form an intravitreal drug depot. Hydrolysis of the copolymer will automatically lead to the release of L-lactic acid, which will convert to L-lactate at physiological pH, thereby providing a carrier and pro-drug in one. In vitro and ex vivo release studies demonstrate an L-lactic acid release over several weeks. Biocompatibility of the co-polymer and its degradation products is shown on a human retinal pigment epithelial cell line and on ex vivo retinal tissues. A low molecular weight copolymer (1200 g/mol) with low polydispersity has promising properties with a zero order release profile, good biocompatibility and injectability.
Marieke Veurink; Lutz Asmus; Maren Hennig; Béatrice Kaufmann; Lena Bagnewski; Arnd Heiligenhaus; Efstratios Mendrinos; Constantin J Pournaras; Robert Gurny; Michael Möller
Related Documents :
350289 - Folate polyglutamates in t4d bacteriophage and t4d-infected escherichia coli.
24204549 - Correction: retinal amino acid neurochemistry of the southern hemisphere lamprey, geotr...
8809639 - Human plasma concentrations of r, s, and racemic flurbiprofen given as a toothpaste.
3878689 - Antibacterial activity of phosphanilic acid, alone and in combination with trimethoprim.
9675009 - Purification and characterization of intrauterine folate-binding proteins from swine.
2543289 - The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomega...
3083089 - Effect of tryptophan on 2,4-dichlorophenoxyacetic acid toxicity in the nitrogen-fixing-...
19158029 - Free amino acids as phagostimulants in cricket nuptial gifts: support for the 'candymak...
17764919 - The safety of evening primrose oil in epilepsy.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-8
Journal Detail:
Title:  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences     Volume:  -     ISSN:  1879-0720     ISO Abbreviation:  Eur J Pharm Sci     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9317982     Medline TA:  Eur J Pharm Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013. Published by Elsevier B.V.
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, 1211, Geneva, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A Functional and Genetic Analysis of SOD2 Promoter Variants and their Contribution to Age-Related He...
Next Document:  In vitro, ex vivo and in vivo examination of buccal absorption of metoprolol with varying pH in TR14...